• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[尿激酶在动物模型中对脑血栓栓塞的溶栓作用]

[Thrombolysis of cerebral thromboembolism by urokinase in an animal model].

作者信息

Hirschberg M, Korves M, Koc I, Hofferberth B, Wiesmann W

机构信息

Klinik für Neurologie und Radiologie, Universität Münster.

出版信息

Schweiz Med Wochenschr. 1987 Nov 14;117(46):1811-3.

PMID:3423767
Abstract

The majority of ischemic cerebral insults are caused by thromboembolism. In animal experiments we have investigated the possibility of reperfusing ischemically damaged brain tissue by thrombolysis of cerebral emboli. 1, 3 and 5 hours after cerebral infarction due to thromboembolism, thrombolytic treatment with urokinase (1000 IU/kg/min) was started. Thrombolysis, monitored by angiography, was successful in all cases (n = 15). In all cases the fall in fibrinogen, alpha 2-antiplasmin and plasminogen reflected systemic fibrinolytic effects. Anatomo-pathologic investigation of the brains revealed no intracerebral bleeding complications. The results of the study suggest a favourable effect of urokinase on acute ischemic cerebral infarction.

摘要

大多数缺血性脑损伤是由血栓栓塞引起的。在动物实验中,我们研究了通过溶解脑栓塞对缺血性损伤的脑组织进行再灌注的可能性。在血栓栓塞导致脑梗死1、3和5小时后,开始用尿激酶(1000 IU/kg/分钟)进行溶栓治疗。通过血管造影监测,溶栓在所有病例(n = 15)中均成功。在所有病例中,纤维蛋白原、α2-抗纤溶酶和纤溶酶原的下降反映了全身纤溶作用。对大脑的解剖病理学研究未发现脑内出血并发症。该研究结果表明尿激酶对急性缺血性脑梗死有良好作用。

相似文献

1
[Thrombolysis of cerebral thromboembolism by urokinase in an animal model].[尿激酶在动物模型中对脑血栓栓塞的溶栓作用]
Schweiz Med Wochenschr. 1987 Nov 14;117(46):1811-3.
2
[Experimental thrombolysis of thromboembolisms in the middle cerebral artery circulatory area].[大脑中动脉循环区域血栓栓塞的实验性溶栓治疗]
Rofo. 1988 Feb;148(2):117-20. doi: 10.1055/s-2008-1048161.
3
Oral urokinase: absorption, mechanisms of fibrinolytic enhancement and clinical effect on cerebral thrombosis.
Folia Haematol Int Mag Klin Morphol Blutforsch. 1986;113(1-2):122-36.
4
Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits [corrected].动脉内注射组织型纤溶酶原激活剂和尿激酶对兔脑循环中自体动脉栓子的影响[校正后]
Stroke. 1990 Nov;21(11):1594-9. doi: 10.1161/01.str.21.11.1594.
5
[Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?].[兔体内重组组织型纤溶酶原激活剂(rt-PA)溶栓结果是否取决于血栓的红细胞和纤维蛋白含量?]
Rofo. 2004 Jan;176(1):98-105. doi: 10.1055/s-2004-814671.
6
[A rat middle cerebral artery thrombosis model for evaluation of thrombolytic and antithrombotic agents].
Yao Xue Xue Bao. 1995;30(9):662-7.
7
Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.组织型纤溶酶原激活剂与尿激酶在体外的相对纤维蛋白溶解、纤溶及溶栓特性比较
Thromb Haemost. 1981 Jun 30;45(3):225-9.
8
Thrombolytic intervention in acute thrombotic and embolic stroke.急性血栓形成和栓塞性卒中的溶栓干预
Z Kardiol. 1993;82 Suppl 2:89-104.
9
Dynamic change of coagulation and anticoagulation markers of patients with acute cerebral infarction during intravenous urokinase thrombolysis.急性脑梗死患者静脉注射尿激酶溶栓期间凝血及抗凝标志物的动态变化
Neurol Res. 2006 Jan;28(1):46-9. doi: 10.1179/016164106X91861.
10
[Clinical effects of urokinase and sodium ozagrel in patients with acute symptomatic lacunar infarction].[尿激酶与奥扎格雷钠治疗急性症状性腔隙性脑梗死的临床疗效]
No To Shinkei. 1996 Sep;48(9):805-9.